HRMY · Harmony Biosciences Holdings, Inc.
$38.12
-0.38 (-0.99%)
At close · Aug 14
Market Cap
$2.22B
Shares
58.24M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
$150,000,000
as of 2026-06-30
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-10-01 | $200,000 | $150,000 | 2026-06-30 | — | 10-Q , filed 2026-08-04 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-12-31 | $100,000,000 | 10-K, filed 2026-02-24 |
| 2020-12-31 | $167,000 | 10-K, filed 2023-02-21 |
Key facts
CIK
1802665
CUSIP
413197104
13F (30d)
303 filings
297 filers
Visit website
Investor relations